{"database": "press", "table": "releases", "rows": [["https://www.moran.senate.gov/public/index.cfm/news-releases?ID=767574F9-9341-4BCC-B37B-E1AB66C5DFCF", "Sen. Moran Announces $43 Million Federal Investment for New KU Cancer Center Building", "2023-06-28", "2023", "2023-06", "Republican", "Senate", "KS", "Jerry Moran", "M000934", "www.moran.senate.gov", "moran", "https://www.moran.senate.gov/public/index.cfm/news-releases", "scraper", "WASHINGTON \u2013 U.S. Senator Jerry Moran (R-Kan.) announced a $43 million federal investment to plan and help build a new cancer research facility at The University of Kansas Cancer Center. Sen. Moran was joined by Acting National Institutes of Health (NIH) Director Lawrence Tabak in Kansas City to announce the federal investment.\n\nThe funding was secured by Sen. Moran in the FY2023 Appropriations Package through his role as the Ranking Member of the Appropriations Subcommittee on Commerce, Justice and Science and as a member of the Appropriations Subcommittee on Labor, Health and Human Services and Education.\n\n\u201cAfter years of hard work and dedication, The University of Kansas Cancer Center was awarded the NCI\u2019s comprehensive cancer center designation, opening up new possibilities and greater federal investment,\u201d said Sen. Moran. \u201cThe University of Kansas Cancer Center is already a nationally recognized leader in the fight to treat and cure cancer. With a new, state-of-the-art cancer center, The University of Kansas Cancer Center can expand its legacy and capabilities to conduct a greater number of innovative research projects, which will undoubtedly lead to improved treatments for patients.\u201d\n\nThe University of Kansas Cancer Center also received a $100 million gift to help build the cancer center from the Sunderland Foundation. This gift raises the total to $143 million for a building to bring together cancer research, treatment and patient care teams, transforming cancer care in the region.\n\n\u201cWe do big things in Kansas City, due in large part to the generosity and vision of people like Charlie and Kent Sunderland and the Sunderland Foundation. The commitment of our community and elected officials like Senator Moran have placed The University of Kansas Health System and The University of Kansas Cancer Center at the center of Kansas City\u2019s transformation,\u201d said Bob Page, president and CEO of The University of Kansas Health System. \u201cThis new building is more than a building; it is about taking a bold step to say, \u2018We believe we can transform the way cancer research and care is provided in our region, across this country and around the globe.\u2019 We not only will save more lives, we will change more lives and our community for the better.\u201d\n\n\u201cThe University of Kansas Cancer Center is a transformative engine, which will not only reshape how cancer care is delivered but also our community as a destination for the very best cancer care available anywhere,\u201d said Tammy Peterman, M.S., FAAN, president, Kansas City division, and health system executive vice president, chief operating officer and chief nursing officer. \u201cWe are doing things at the cancer center not done anywhere else in the country. With our nationally recognized specialists and world-class care teams, we will deliver even more groundbreaking treatments and innovations.\u201d\n\n\u201cOur vision is for The University of Kansas Cancer Center to be a beacon of hope and a global destination for both those with cancer and for scientists and clinicians seeking to cure cancer,\u201d said Roy Jensen, vice chancellor and director of The University of Kansas Cancer Center. \u201cThis building will be a hub that brings together leading-edge patient care and innovation as we seek to transform both cancer care and cancer research in our quest to cure cancer \u2014 together. Patients treated at NCI-designated cancer centers have a 25% greater chance of survival compared to other cancer centers because of the enhanced relationship between patient care and research. This building will advance our goals even further, serving as a catalyst for breakthroughs that will change cancer care on the national level.\u201d\n\n\u201cThe funding provided by the Sunderland Foundation, combined with the appropriation secured by Senator Moran, will enable the KU Cancer Center to enhance its work in research and patient care while fulfilling its duty to provide public education and outreach programs, especially to diverse communities and high-risk populations,\u201d said KU Chancellor Doug Girod. \u201cMore broadly, by strengthening the KU Cancer Center, this funding elevates the entire university and strengthens KU\u2019s position as a leading national research institution and proud member of the Association of American Universities. We deeply appreciate the Sunderland Foundation and Senator Moran\u2019s continued support of the KU Cancer Center and the university, and we look forward to partnering with them in the future on initiatives that benefit Kansas.\u201d\n\n\u201cAdvancing the KU Cancer Center through this funding and this new building will continue to benefit the University of Kansas Medical Center, its researchers and its students,\u201d said Robert D. Simari, M.D., executive vice chancellor of KU Medical Center. \u201cIt also means more collaboration, more cutting-edge research and more opportunities to pursue team science with researchers, scientists and faculty members throughout our schools of Medicine, Nursing and Health Professions.\u201d\n\nCurrently, The University of Kansas Cancer Center\u2019s labs and researchers are scattered across multiple campuses in the Kansas City metro area and Lawrence, Kansas. This grant will help the cancer center consolidate its labs, research and care into one center.\n\nThe new facility will be located on the 39th and Rainbow campus. It will be built in phases, with the goal of breaking ground on the first phase by the earliest in the fall of 2024. The new building will bring expanded cancer care and research together in one place. Patients will have access to more innovative clinical trials and groundbreaking therapies developed on site.\n\n# # #", 1, "2026-03-30T01:40:41Z", "2026-04-06T18:15:57Z"]], "columns": ["url", "title", "date", "year", "month", "party", "chamber", "state", "member_name", "bioguide_id", "domain", "scraper", "source", "date_source", "text", "has_text", "collected_at", "updated_at"], "primary_keys": ["url"], "primary_key_values": ["https://www.moran.senate.gov/public/index.cfm/news-releases?ID=767574F9-9341-4BCC-B37B-E1AB66C5DFCF"], "units": {}, "query_ms": 1.6736569814383984, "source": "dwillis/congress-press", "source_url": "https://github.com/dwillis/congress-press", "license": "MIT", "license_url": "https://github.com/dwillis/congress-press/blob/main/LICENSE"}